Skip to main content

Prospects for primary prevention of coronary heart disease

  • Chapter
Atherosclerosis and Cardiovascular Disease
  • 69 Accesses

Abstract

Major contributors to coronary heart disease have been identified through epidemiologic research. These risk factors fall into a number of interdependent categories including: atherogenic personal attributes, living habits which promote them, signs of a compromised circulation and host susceptibility to these risk factors. Modifiable atherogenic risk attributes include blood lipids, blood pressure, glucose tolerance and fibrinogen. The risk associated with each is markedly affected by those others which coexist. Modifiable living habits exist which promote these atherogenic traits including overeating, unrestrained weight gain, faulty diet, cigarette smoking, and lack of exercise. Innate susceptibility is signified by a family history of premature vascular disease, identifying persons in particular need of risk factor control. At a given level of serum total cholesterol risk varies widely depending on total/HDL-cholesterol ratio providing an efficient and practical means for assessing the joint effect of the two-way traffic of total cholesterol. Optimal treatment must improve this lipid profile. Diabetes on average doubles CHD mortality imparting greater risk in women than men and exerting an independent effect. Risk in diabetics varies widely depending on coexistent risk factors providing a means for reducing the risk. The same applies for hypertension and dyslipidemia. Preclinical indicators of a compromised coronary circulation and ischemic myocardial involvement include ECG evidence of left ventricular hypertrophy, blocked intraventricular function, repolarization abnormality and abnormal response to exercise. Such persons are in dire need of correction of modifiable risk factors. Optimal risk predictions require a quantitative synthesis of risk factors into a composite estimate. Handbooks, hand calculators and P.C. software, based on multiple logistic risk formulations have been devised for office use requiring only ordinary office procedures and simple laboratory tests to measure the risk factor ingredients. Preventive management as well as risk estimation should be multifactorial if good results are to be acheived. Preventive strategies should include public health measures to alter the ecology so as to shift the whole distribution of risk factors to a more favorable level, health education to enable people to protect their own health and preventive medicine for high risk candidates. Greater skill at modifying behavior must be developed to carry out such risk factor interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gordon, T., Kannel, W.B. (1971) ‘Premature mortality from coronary heart disease. The Framingham Study’, JAMA 215, 1617–1625.

    Article  CAS  PubMed  Google Scholar 

  2. Kannel, W.B., McGee, D.L. (1976) ‘A general cardiovascular risk profile: The Framingham Study’, Am J Cardiol 38, 46–51.

    Article  CAS  PubMed  Google Scholar 

  3. Kannel, W.B. (1983) ‘High density lipoproteins: Epidemiologic profile and risks of coronary artery disease’, Am J Cardiol 52, 9B–12B.

    Article  CAS  PubMed  Google Scholar 

  4. Report of Intersociety Commission for Heart Disease Resources. (1984) ‘Optimal resources for primary prevention of atherosclerotic disease’, Circ 70, 155A–205A.

    Google Scholar 

  5. Kannel, W.B., Sorlie, P., Gordon, T. (1980) ‘Labile hypertension: A faulty concept?’ Circ 61, 1183–1187.

    CAS  Google Scholar 

  6. Kannel, W.B., Dawber, T.R., McGee, D.L. (1980) ‘Perspectives on systolic hypertension: The Framingham Study’, Circ 61, 1179–1182.

    CAS  Google Scholar 

  7. Kannel, W.B., Wolf, P.A., McGee, D.L. (1981) ‘Systolic blood pressure, arterial rigidity and risk of stroke: The Framingham Study’, JAMA 245, 1442–1448.

    Article  PubMed  Google Scholar 

  8. Kannel, W.B., McGee, D.L., Castelii, W.P. (1984) ‘Latest perspective on cigarette smoking and cardiovascular disease: The Framingham Study’, J Cardiac Rehav 4, 267–277.

    Google Scholar 

  9. Kannel, W.B., McGee, D.L. (1979) ‘Diabetes arid cardiovascular disease: The Framingham Study’, JAMA 241, 2035–2038.

    Article  CAS  PubMed  Google Scholar 

  10. Kannel, William B., Gordon, Tavia (1974) The Framingham Study: An epidemiologic investigation of cardiovascular disease. Section 30, Monograph. Some characteristics related to the incidence of cardiovascular disease and death. 18 year foolow-up. U.S. Dept., HEW, PHS, NIH, DHEW, Publication No. (NIH)74–599.

    Google Scholar 

  11. Kannel, W.B., Sorlie, W.P. (1981) ‘Left ventricular hypertrophy in hypertension. Prognostic and pathogenetic implications. The Framingham Study’, In, The Heart in Hypertension. Ed., B. E. Strauer, Springer-Verlag Publishing, Berlin pp. 223–242.

    Google Scholar 

  12. Kannel, W.B., Belanger, A.J., D’Agostino, R.B., Israel, I. (1986) ‘Physical activity and physical demand on the job and risk of cardiovascular disease and death. The Framingham Study’, Am Heart J 112, 820–825.

    Article  CAS  PubMed  Google Scholar 

  13. Kannel, W.B., Eaker, E.D. (1986) ‘Psychosocial and other features of coronary heart disease: Insights from the Framingham Study’, Am Heart J, 112,5, 1066 - 1073.

    Google Scholar 

  14. Kannel, W.B., Hjortland, M.C., McNamara, P.M. (1976) ‘Menopause and risk of cardiovascular disease: The Framingham Study’, Ann Intern Med 85, 447.

    CAS  PubMed  Google Scholar 

  15. Wilson, P.W.F., Garrison, R.J., Castelli, W.P. (1985) ‘Post-menopausal estrogen use, cigarette smoking and cardiovascular morbidity in women over 50. The Framingham Study’, N Engl J Med, 313, 1038–1043.

    Article  CAS  PubMed  Google Scholar 

  16. Thorn, T., Kannel W.B. (1981) ‘Downward trend in cardiovascular mortality’, Annual Rev Med 32, 427–434.

    Article  Google Scholar 

  17. Kannel, W.B., Abbott, R.D. (1984) ‘Incidence and prognosis of unrecognized myocardial infarction: An update on the Framingham Study’, N Engl J Med 311, 1144.

    Article  CAS  PubMed  Google Scholar 

  18. Wilhelmsen, L., Svansudd, M.D., Korson-Bengtsenk. (1984) ‘Fibrinogen as a risk factor for stroke and myocardial infarction’, N Engl J Med 311, 501–505.

    Article  CAS  PubMed  Google Scholar 

  19. Snowden, C.B., McNamara, P.M., Garrison, R.J. (1980) ‘Predicting CHD in siblings. A multivariate assessment. The Framingham Study’, Am J Epidemiol 115, 217–222.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Kannel, W.B. (1990). Prospects for primary prevention of coronary heart disease. In: Descovich, G., Gaddi, A., Magri, G., Lenzi, S. (eds) Atherosclerosis and Cardiovascular Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0731-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0731-7_4

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6814-7

  • Online ISBN: 978-94-009-0731-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics